Cargando…

CELLULAR SENESCENCE AS A THERAPEUTIC TARGET FOR GEROSCIENCE-GUIDED CLINICAL TRIALS

The geroscience hypothesis holds that targeting fundamental mechanisms of aging has the potential to prevent or reduce severity of multiple age-related diseases. Cellular senescence is a key mechanism that may be driving disease in human aging, including Idiopathic pulmonary fibrosis (IPF), a progre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Justice, Jamie N, Nambiar, Anoop M, Tchkonia, Tamar, LeBrasseur, Nathan K, Musi, Nicolas, Kritchevsky, Stephen B, Kirkland, James L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Session 4090 (Symposium)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6845774/ http://dx.doi.org/10.1093/geroni/igz038.2987

Ejemplares similares

CLINICAL TRIALS IN GEROSCIENCE
por: Kaeberlein, Matt, et al.
Publicado: (2019)

BIOMARKER STRATEGIES FOR GEROSCIENCE-GUIDED CLINICAL TRIALS
por: Justice, Jamie N, et al.
Publicado: (2019)

AGING TREATMENT BY COUNTERACTING INTRINSIC DNA DAMAGE AND IMMUNOSENESCENCE
por: Gudkov, Andrei
Publicado: (2019)

AGING INTERVENTIONS GET HUMAN: CAN WE EXTEND HEALTHSPAN?
por: Kennedy, Brian
Publicado: (2019)

TORC1 INHIBITION AS AN IMMUNOTHERAPY TO DECREASE INFECTIONS IN THE ELDERLY
por: Mannick, Joan
Publicado: (2019)

BIOMARKERS OF SENESCENT CELL BURDEN
por: LeBrasseur, Nathan
Publicado: (2019)

USING OBSERVATIONAL DATA TO INFORM CANDIDATE PHENOTYPES FOR GEROSCIENCE TRIALS
por: Sanders, Jason L, et al.
Publicado: (2019)

Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
por: Justice, Jamie N., et al.
Publicado: (2019)

PRESIDENTIAL SYMPOSIUM: EXPANDING THE GEROSCIENCE NETWORK
por: Kaeberlein, Matt
Publicado: (2019)

INTEREST GROUP SESSION—GEROSCIENCE: METHODS FROM BENCH TO POPULATION SCIENCE TO INFORM CONSTRUCTION OF GEROSCIENCE CLINICAL TRIALS
por: Sanders, Jason L, et al.
Publicado: (2019)

EXPANDING THE NETWORK: NONTRADITIONAL ANIMAL MODELS IN GEROSCIENCE
por: Cohen, Alan A
Publicado: (2019)

DEVELOPMENT OF EPIGENETIC MEASURES FOR GEROSCIENCE CLINICAL TRIALS
por: Levine, Morgan E
Publicado: (2019)

The Translational Geroscience Network: Supporting a New Paradigm to Alleviate Age-Related Chronic Disease
por: Justice, Jamie, et al.
Publicado: (2020)

Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability
por: Nambiar, Anoop, et al.
Publicado: (2023)

SENOLYTIC DRUGS: DISCOVERY, TRANSLATION, AND APPLICATION
por: LeBrasseur, Nathan
Publicado: (2019)

Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity
por: Palmer, Allyson K., et al.
Publicado: (2015)

Cellular senescence, geroscience, cancer and beyond
por: Rodier, Francis, et al.
Publicado: (2018)

Targeting cellular senescence in metabolic disease
por: Palmer, Allyson K., et al.
Publicado: (2022)

CIRCULATING BIOMARKERS OF CELL SENESCENCE IN A RANDOMIZED TRIAL OF CALORIC RESTRICTION WEIGHT LOSS
por: Justice, Jamie, et al.
Publicado: (2022)

SENESCENCE-ASSOCIATED SECRETOME COMPONENTS AS BIOMARKERS FOR AGING
por: Zhang, Xu, et al.
Publicado: (2019)

Operationalizing Healthspan as an Outcome for Clinical Trials in Geroscience
por: Justice, Jamie
Publicado: (2021)

Cellular Senescence: A Translational Perspective
por: Kirkland, James L., et al.
Publicado: (2017)

COVID-19 and cellular senescence
por: Schmitt, Clemens A., et al.
Publicado: (2022)

SENESCENCE SECRETOME: BIOMARKERS OF BIOLOGICAL AGING AND POSTOPERATIVE OUTCOMES
por: Schafer, Marissa, et al.
Publicado: (2019)

The First Evaluation of a Geroscience Biomarker Index (TAME-BI) in a Trial of Caloric Restriction and Exercise
por: Justice, Jamie, et al.
Publicado: (2021)

BREAKING GROUND IN TRANSLATIONAL GEROSCIENCE: FROM BIOMARKERS TO CLINICAL TRIALS
por: Justice, Jamie
Publicado: (2022)

Evaluating Health Span in Preclinical Models of Aging and Disease: Guidelines, Challenges, and Opportunities for Geroscience
por: Huffman, Derek M., et al.
Publicado: (2016)

SIGNIFICANT PUBLIC POLICY ISSUES IN THE HEALTH SCIENCES
por: Kritchevsky, Stephen
Publicado: (2019)

PRESIDENTIAL SYMPOSIUM: MULTIDISCIPLINARY EMERGING PERSPECTIVES ON BUILDING AND MAINTAINING NETWORKS IN AGING.
por: Petrovsky, Darina V, et al.
Publicado: (2019)

Cell senescence, the senescence-associated secretory phenotype, and cancers
por: Langhi Prata, Larissa G. P., et al.
Publicado: (2023)

ESPO AND NIA BUTLER-WILLIAMS SCIENTIFIC SYMPOSIUM: INFLUENCE OF RACE, ETHNICITY, AND EXPERIENCE ON HEALTH IN AGING
por: Justice, Jamie N, et al.
Publicado: (2019)

Targeting cellular senescence prevents age-related bone loss in mice
por: Farr, Joshua N., et al.
Publicado: (2017)

Cellular Senescence in Idiopathic Pulmonary Fibrosis
por: Kellogg, D. L., et al.
Publicado: (2021)

Cellular senescence mediates fibrotic pulmonary disease
por: Schafer, Marissa J., et al.
Publicado: (2017)

Targeting senescent cells enhances adipogenesis and metabolic function in old age
por: Xu, Ming, et al.
Publicado: (2015)

Exercise Prevents Diet-Induced Cellular Senescence in Adipose Tissue
por: Schafer, Marissa J., et al.
Publicado: (2016)

Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age
por: Cummings, Steven R., et al.
Publicado: (2022)

Challenges in developing Geroscience trials
por: Rolland, Yves, et al.
Publicado: (2023)

Deleted in Breast Cancer 1 regulates cellular senescence during obesity
por: Escande, Carlos, et al.
Publicado: (2014)

Targeting Senescent Cells to Counter Aging and Aging-Related Conditions
por: LeBrasseur, Nathan
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_elngma1jjur6pokho22s8oum3i